ELMINA SUMMERALL: Open Payments
NPI 1427250620 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 20 payments from 5 companies in 2025. Trend: 2023 $927 · 2024 $757 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $164 |
| Supernus Pharmaceuticals, Inc. | 7 | $132 |
| ABBVIE INC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Auvelity, Qelbree, VRAYLAR, REXULTI, CAPLYTA.
Industry payments across SC — which companies pay providers there.
